10-K Decoder · All companies

Nektar Therapeutics

NKTR · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$55.2M$98.4M−43.9%
Operating income−$140M−$105M−33.2%
Net income−$164M−$119M−37.9%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 13, 2026

$Q3 2026Year earlierChange
Revenue$9.40M$11.8M−20.3%
Operating income−$57.8M−$31.7M−82.3%
Net income−$55.7M−$35.5M−56.9%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Nektar's revenue in FY2025?
$55.2M in FY2025 (Fiscal year ended Dec 31, 2025), −43.9% vs $98.4M a year earlier, per its 10-K filed Mar 2026.
Was Nektar profitable in FY2025?
No: net income was −$164M and operating income −$140M in FY2025.
What was Nektar's revenue in Q3 2026?
$9.40M (−20.3% vs a year earlier), per its Form 10-Q filed Nov 13, 2026.